Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vita Life Sciences Limited ( (AU:VLS) ) has provided an update.
Vita Life Sciences Limited announced the cessation of 104,392 ordinary fully paid securities as part of an on-market buy-back, effective November 24, 2025. This move is likely to impact the company’s capital structure and could influence its market positioning by potentially increasing shareholder value through a reduction in outstanding shares.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of a range of health supplements and related products. The company is known for its commitment to enhancing health and well-being through innovative and high-quality offerings.
Average Trading Volume: 15,135
Technical Sentiment Signal: Buy
Current Market Cap: A$132.5M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.